Lymphoid Malignancy
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Assess the Oral Bioavailability of a New ABT-263 Formulation in Subjects With Cancer (NCT00982566) | AbbVie | 2009-10-01 |
Track Lymphoid Malignancy automatically
Every clearance here is in the API, with alerts when new ones post.